SPY316.23-0.82 -0.26%
DIA261.05-1.95 -0.74%
IXIC10,454.65+21.00 0.20%

HC Wainwright & Co. Initiates Coverage On Flexion Therapeutics with Buy Rating, Announces Price Target of $25

HC Wainwright & Co. initiates coverage on Flexion Therapeutics (NASDAQ:FLXN) with a Buy rating and announces Price Target of $25.

Benzinga · -
HC Wainwright & Co. initiates coverage on Flexion Therapeutics (NASDAQ: FLXN) with a Buy rating and announces Price Target of $25.